Clinical studies recruiting near Lone Tree

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · UCHealth Lone Tree Health Center · NRG Oncology · NCT05624996 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · Urology Associates, Lone Tree · CG Oncology, Inc. · NCT06567743 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente-Lone Tree · NRG Oncology · NCT05174169 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Kaiser Permanente-Lone Tree · Alliance for Clinical Trials in Oncology · NCT06931340 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Kaiser Permanente-Lone Tree · Alliance for Clinical Trials in Oncology · NCT06876714 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · UCHealth Lone Tree Health Center · Canadian Cancer Trials Group · NCT06592924 Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutation
Phase N/A · Lone Tree Medical Center · University of Colorado, Denver · NCT03958565 The Immune System's Response to Young Women's Breast Cancer
Phase N/A · UCHealth Lone Tree Medical Center · University of Colorado, Denver · NCT01503190 Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Im
Phase 1/Phase 2 · Rocky Mountain Cancer Centers - Lone Tree /ID# 272603 · AbbVie · NCT06772623 Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Inva
Phase 2 · UCHealth Lone Tree Health Center · National Cancer Institute (NCI) · NCT07061964 Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
Phase 2 · Lone Tree Medical Center · University of Colorado, Denver · NCT05969496 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · UCHealth Lone Tree Health Center · NRG Oncology · NCT05327686 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · UCHealth Lone Tree Health Center · NRG Oncology · NCT04852887 Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · University of Colorado Health - Lone Tree Medical Center ( S · Merck Sharp & Dohme LLC · NCT06136624 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · UCHealth Lone Tree Health Center · National Cancer Institute (NCI) · NCT06058377 An Internet-based Program to Help Cancer Survivors Manage Pain
NA · Kaiser Permanente-Lone Tree · Wake Forest University Health Sciences · NCT04462302 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Kaiser Permanente-Lone Tree · NRG Oncology · NCT05080673 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Kaiser Permanente-Lone Tree · National Cancer Institute (NCI) · NCT05987241 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · USOR - Rocky Mountain Cancer Centers - Lone Tree · Mirati Therapeutics Inc. · NCT04613596 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · Kaiser Permanente-Lone Tree · SWOG Cancer Research Network · NCT03418961 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Kaiser Permanente-Lone Tree · National Cancer Institute (NCI) · NCT04267848 A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resist
Phase 3 · University of Colorado Health - Lone Tree Medical Center ( S · Merck Sharp & Dohme LLC · NCT06136650 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Kaiser Permanente-Lone Tree · SWOG Cancer Research Network · NCT03851445 The Vanguard Study: Testing a New Way to Screen for Cancer
NA · Kaiser Permanente-Lone Tree · National Cancer Institute (NCI) · NCT06995898 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L
Phase 2 · UCHealth Lone Tree Health Center · SWOG Cancer Research Network · NCT05642572 A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Phase 3 · Rocky Mountain Cancer Centers-Lone Tree · Incyte Corporation · NCT07623200 Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Phase 3 · Kaiser Permanente-Lone Tree · National Cancer Institute (NCI) · NCT04181060 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After
Phase 3 · Kaiser Permanente-Lone Tree · Alliance for Clinical Trials in Oncology · NCT05812807 Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ C
Phase 3 · UCHealth Lone Tree Health Center · Children's Oncology Group · NCT03067181 Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Particip
Phase 3 · Rocky Mountain Cancer Centers - Lone Tree /ID# 278320 · AbbVie · NCT06158841

Look up another city

Look up another condition